ZAP Surgical 任命 业 内 资 深人士 领导 中国市 场 的拓展工作
加利福尼亚州圣卡洛斯市 (美国商业资讯)–ZAP-X®陀螺放射外科(Gyroscopic Radiosurgery®)平台的制造商ZAP Surgical Systems, Inc.今天宣布任命Jie Sun博士为副总裁, 负责大中华区,任命Calvin...
View ArticleZAP Surgical Appoints Industry Veterans to Lead Chinese Market Expansion
SAN CARLOS, Calif. ZAP Surgical Systems, Inc., maker of the ZAP-X® Gyroscopic Radiosurgery® platform, today announced the appointment of Jie Sun, PhD, as Vice President, Greater China, and Calvin...
View Article新研究发现,Masimo SedLine® PSi和DSA联用或可显著减少术后谵妄
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天发布《神经内科前沿》(Frontiers in Neurology)上发表的一项前瞻性研究的结果。在该研究中,北京首都医科大学Na Xu博士及其同事对Root®平台上Masimo...
View ArticleAIRS Medical Receives FDA 510(k) Clearance for AI-Powered MRI Reconstruction...
SEOUL, South Korea AIRS Medical Inc., a healthcare startup based in South Korea, announced FDA 510(k) clearance of its first product SwiftMR™. SwiftMR™ is an AI-powered MRI reconstruction software...
View ArticleICURE、アルツハイマー型認知症治療のドネペジルパップ剤が世界初で品目許可の承認を獲得
韓国ソウル (ビジネスワイヤ) – 韓国の製薬会社ICURE (KOSDAQ: 175250)は、開発したアルツハイマー型認知症治療剤ドネペジル(Donepezil)パップ剤が...
View ArticleAn AI-based Medical Digitization Consortium in Korea Starts off Toward...
SEOUL, South Korea “K-Avengers that join forces to accelerate AI-based medical digitization service now expand to the global market.” A large enterprise, small and medium-sized companies and...
View Articleマシモ製のSedLine® PSiとDSAの使用により術後せん妄を大幅に低減し得ることが新たな研究で判明
スイス・ヌーシャテル (ビジネスワイヤ) — マシモ(NASDAQ: MASI)は本日、Frontiers in Neurology誌に掲載された前向き研究の知見を発表しました。本研究では、北京の首都医科大学のDr. Na Xuと同僚らが、Root®に搭載されたMasimo...
View ArticleGuided Therapeutics Announces Start of Chinese Clinical Trial for Approval to...
PEACHTREE CORNERS, Ga. Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, based on its patented biophotonic technology, announced today that enrollment and...
View Article中智全球和Milestone手术中心宣布使用“信任即技术”改善患者转归并加快创收
德克萨斯州弗劳尔芒德和科罗拉多州帕克 SEC³URE Ethos、SEC³URE Passport、Link&GO!、BioBytes™和BioBytes™Visitor背后的创新企业中智全球(IntelliCentrics, 6819.HK)宣布,由医生所有的女性专科门诊手术中心Milestone手术中心选择了基于信任的超大医疗技术社区SEC³URE...
View ArticleICURE用于治疗阿尔茨海默氏症痴呆的多奈哌齐贴剂全球首次获得品种许可批准
韩国首尔 (美国商业资讯)–韩国制药厂商ICURE(KOSDAQ: 175250)日前发布消息称,其开发的阿尔茨海默氏症痴呆治疗药物多奈哌齐(Donepezil)贴剂已获得韩国食品医药品安全处颁发的正式品种许可。4月份提出申请之后,仅仅约7个月就获得了多奈哌齐贴剂的品种许可批准,ICURE凭借此次获批,收获了多奈哌齐贴剂全球首次成功实现商业化的头衔。...
View Article美国FDA核准BESREMi® (Ropeginterferon α-2b)
维也纳 (美国商业资讯)–2009年,AOP Orphan获得独家授权,可在欧洲、独立国家联合体(CIS)和中东市场开展Ropeginterferon...
View ArticleTROPION-Breast01 Phase 3 Trial of Datopotamab Deruxtecan Initiated in...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the first patient was dosed in the global TROPION-Breast01 phase 3 trial...
View ArticleQuizartinib Added to Chemotherapy Demonstrates Superior Overall Survival...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced positive topline results from the global pivotal QuANTUM-First phase 3 trial...
View ArticleBeiGene Initiates First-in-Human Phase 1 Clinical Trial of Investigational...
CAMBRIDGE, Mass. & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160), a global, science-driven biotechnology company focused on developing innovative and affordable medicines, today announced that the...
View ArticleQurient Announces Collaboration Agreement with MSD to Evaluate Selective...
SEONGNAM-SI, Korea Qurient Co. Ltd. (KRX: 115180), a clinical-stage biotech company based in Korea, today announced that the company has entered into a clinical collaboration agreement with MSD, a...
View ArticleExscientia公布2021年第三季度业务更新
英格兰牛津 (美国商业资讯)–Exscientia (Nasdaq: EXAI): 本新闻稿包含多媒体。此处查看新闻稿全文: https://www.businesswire.com/news/home/20211122006704/zh-CN/ (图示:美国商业资讯)...
View ArticleCanon Medical Reinforces Commitment to AI Innovation With New Altivity Brand
OTAWARA, Japan Canon Medical has today announced the launch of Altivity, a new AI innovation brand, that consolidates machine learning and deep learning technologies to deliver uncompromised quality...
View ArticleMDoloris Medical Systems Announces the Regulatory Clearance and the Upcoming...
PARIS MDoloris Medical Systems, a leader in the field of objective pain monitoring during anesthesia, announces today the regulatory clearance and marketing approval of its HFVI MOC-9, High...
View ArticleMTTIとモンロールが無担体Lu-177の臨床供給契約を締結
米ペンシルベニア州ウェストチェスター & イスタンブール エジザージュバシュ・モンロール・ニュークリア・プロダクツ(以下、モンロール)は本日、臨床段階にあるバイオテクノロジー企業として革新的な希少がん向け治療薬の開発に傾注しているモレキュラー・ターゲティング・テクノロジーズ(MTTI)との間で、医療用放射性同位元素である無担体177Luの供給契約を締結したと発表しました。...
View ArticleMTTI和Monrol已签署镥-177 n.c.a.临床供应协议
宾夕法尼亚州西切斯特和伊斯坦布尔 –(美国商业资讯)–Eczacıbaşı-Monrol Nuclear Products Co. (Monrol)今天宣布与专注于开发用于罕见癌症之创新疗法的临床阶段生物技术公司Molecular Targeting Technologies, Inc. (MTTI)达成医用放射性同位素无载体177镥(n.c.a.177镥)的供应协议。...
View Article